Pharma

Global Biomarker Tests Market Opportunities and Forecast 2020-2027

  • DLR2149
  • 15 March, 2022
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Biomarker Tests Market, By Applications (Cancer, Cardiovascular, Infectious Diseases, Central Nervous System, Others), By End-Use Industry (Pharma & Biotech Companies, Diagnostic Tool Companies, Clinical Laboratories, Others), and opportunities and forecast 2020-2027

Biomarker Tests Market Overview

Biomarker testing is frequently referred to as molecular testing or genetic testing. To help the community, professionals in the healthcare biomarker testing market will sometimes go through the diagnostic test method to explain and support whatever clinical outcomes are proclaimed. Clinical biomarker testing is another name for this. Next-generation sequencing technologies, ultra-high-throughput sequencing, the expanding prevalence of genetic illnesses, and the increased potential for biomarkers and targeted therapeutics are all examples of where the biomarker is applied.
 
The biomarker test market is exploding in the global market as patients become more involved in personal health care. Because of next-generation sequencing, the increased prevalence of genetic illnesses, and the growing potential for biomarkers in specifically targeted medicines, there is an increasing demand for biomarkers in other technologies. The biomarker test market is growing rapidly in the global market due to a variety of factors, including developments in health care and individuals becoming more health or fitness conscious.
 
The global biomarker test market is booming, but it's hampered by a lack of understanding about biomarkers' potential applications, a tight regulatory framework, and a scarcity of research.
 
Report Metric Details
Market size available for years 2019–2027
Base year considered 2019
Forecast period 2020–2027
Forecast unit Value (USD Million)
Segments covered Applications, End-Use Industry, and Region.
Regions covered North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA)
Companies covered Hoffmann-La Roche AG, Novartis AG, Pfizer Inc., GlaxoSmithKline plc, GE Healthcare, Medtronics plc, Quest Diagnostics.


Covid-19 Impact on Biomarker Tests Market
 
In addition, the current Biomarker Tests Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Biomarker Tests Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
 
Biomarker Tests Market Segment Overview



Based on the Application, Cancer is one of the most prominent segments in the global Biomarker Tests Market. Because of the rising number of cancer cases and people's increasing needs, the Cancer segment dominated the market. Rapid and accurate diagnostic tools, as well as personalized treatments, have raised demand.
 
Biomarker Tests Market, By Applications
·       Cancer
·       Cardiovascular
·       Infectious Diseases
·       Central Nervous System
·       Others

Biomarker Tests Market, By End-Use Industry
·       Pharma & Biotech Companies
·       Diagnostic Tool Companies
·       Clinical Laboratories
·       Others

Biomarker Tests Market Regional Overview

Geographically, North America commanded a major share of the market and is predictable to maintain its supremacy over the forecast period. This is attributable to the expanding disease burden and the presence of key market participants, as well as favorable government rules and regulatory agencies, which are increasing the number of biomarker testing adoptions in the United States and Canada. Europe is the second-largest region, thanks to a growing market in biomarker testing, which is attributed to an increase in the number of cases of cardiovascular diseases, thriving healthcare sectors, and increasing technological developments in products. Moreover, Asia Pacific has been recorded as having the highest CAGR during the anticipated period because of its prominent biomarker companies and increasing R&D expenditure in all developing countries.
 
Biomarker Tests Market, By Geography
 
·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
 
Biomarker Tests Market, Key Players

·       Hoffmann-La Roche AG
·       Novartis AG
·       Pfizer Inc.
·       GlaxoSmithKline plc
·       GE Healthcare
·       Medtronics plc
·       Quest Diagnostics

Frequently Asked Questions (FAQ) :

Q1. What are the driving factors for the global Biomarker Tests market?

A. Market expansion is being sparked by most people's rising need for personalized health care

Q2. What are the restraining factors for the global Biomarker Tests market?

A. The growth of the global Biomarker Tests market is hampered by a lack of understanding about biomarkers' potential applications, a tight regulatory framework, and a scarcity of research

Q3. Which segment is projected to hold the largest share in the global Biomarker Tests market?

A. The cancer segment is projected to hold the largest share in the global Biomarker Tests market

Q4. Which region holds the largest share in the global Biomarker Tests market?

A. North America holds the largest share in the global Biomarker Tests market.

Q5. Which are the prominent players in the global Biomarker Tests market?

A. Hoffmann-La Roche AG, Novartis AG, Pfizer Inc., GlaxoSmithKline plc, GE Healthcare, Medtronics plc, Quest Diagnostics. are some key players in the global Biomarker Tests market
Biomarker Tests Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Biomarker Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Applications
        • 5.2.1. Cancer
        • 5.2.2. Cardiovascular
        • 5.2.3. Infectious Diseases
        • 5.2.4. Central Nervous System
        • 5.2.5. Others
      • 5.3. Market Analysis, Insights and Forecast – By End-Use Industry
        • 5.3.1. Pharma & Biotech Companies
        • 5.3.2. Diagnostic Tool Companies
        • 5.3.3. Clinical Laboratories
        • 5.3.4. Others
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East and Africa

      6. North America Biomarker Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Applications
        • 6.2.1. Cancer
        • 6.2.2. Cardiovascular
        • 6.2.3. Infectious Diseases
        • 6.2.4. Central Nervous System
        • 6.2.5. Others
      • 6.3. Market Analysis, Insights and Forecast – By End-Use Industry
        • 6.3.1. Pharma & Biotech Companies
        • 6.3.2. Diagnostic Tool Companies
        • 6.3.3. Clinical Laboratories
        • 6.3.4. Others
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe Biomarker Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Applications
        • 7.2.1. Cancer
        • 7.2.2. Cardiovascular
        • 7.2.3. Infectious Diseases
        • 7.2.4. Central Nervous System
        • 7.2.5. Others
      • 7.3. Market Analysis, Insights and Forecast – By End-Use Industry
        • 7.3.1. Pharma & Biotech Companies
        • 7.3.2. Diagnostic Tool Companies
        • 7.3.3. Clinical Laboratories
        • 7.3.4. Others
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific Biomarker Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Applications
        • 8.2.1. Cancer
        • 8.2.2. Cardiovascular
        • 8.2.3. Infectious Diseases
        • 8.2.4. Central Nervous System
        • 8.2.5. Others
      • 8.3. Market Analysis, Insights and Forecast – By End-Use Industry
        • 8.3.1. Pharma & Biotech Companies
        • 8.3.2. Diagnostic Tool Companies
        • 8.3.3. Clinical Laboratories
        • 8.3.4. Others
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East and Africa Biomarker Tests Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Applications
        • 9.2.1. Cancer
        • 9.2.2. Cardiovascular
        • 9.2.3. Infectious Diseases
        • 9.2.4. Central Nervous System
        • 9.2.5. Others
      • 9.3. Market Analysis, Insights and Forecast – By End-Use Industry
        • 9.3.1. Pharma & Biotech Companies
        • 9.3.2. Diagnostic Tool Companies
        • 9.3.3. Clinical Laboratories
        • 9.3.4. Others
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Hoffmann-La Roche AG
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Novartis AG
      • 10.6. Pfizer Inc.
      • 10.7. GlaxoSmithKline plc
      • 10.8. GE Healthcare
      • 10.9. Medtronics plc
      List of Figures

      Figure 1: Global Biomarker Tests Market Revenue Breakdown (USD Billion, %) by Region, 2019 & 2027
      Figure 2: Global Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 3: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 4: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 5: Global Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 6: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 7: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 8: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 9: Global Biomarker Tests Market Forecast (USD Billion), by Others, 2016-2027
      Figure 10: Global Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 11: Global Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 12: Global Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 13: Global Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 14: Global Market Forecast (USD Billion), by Others, 2016-2027
      Figure 15: Global Market Value (USD Billion), by Region, 2019 & 2027
      Figure 16: North America Biomarker Tests Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 17: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 18: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 19: North America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 20: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 21: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 22: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 23: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 24: North America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 25: North America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 26: North America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 27: North America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 28: North America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 29: North America Market Forecast (USD Billion), by U.S., 2016-2027
      Figure 30: North America Market Forecast (USD Billion), by Canada, 2016-2027
      Figure 31: Latin America Biomarker Tests Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 32: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 33: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 34: Latin America Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 35: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 36: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 37: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 38: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 39: Latin America Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 40: Latin America Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 41: Latin America Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 42: Latin America Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 43: Latin America Market Forecast (USD Billion), by Others, 2016-2027
      Figure 44: Latin America Market Forecast (USD Billion), by Brazil, 2016-2027
      Figure 45: Latin America Market Forecast (USD Billion), by Mexico, 2016-2027
      Figure 46: Latin America Market Forecast (USD Billion), by Rest of Latin America, 2016-2027
      Figure 47: Europe Biomarker Tests Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 48: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 49: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 50: Europe Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 51: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 52: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 53: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 54: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 55: Europe Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 56: Europe Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 57: Europe Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 58: Europe Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 59: Europe Market Forecast (USD Billion), by Others, 2016-2027
      Figure 60: Europe Market Forecast (USD Billion), by U.K., 2016-2027
      Figure 61: Europe Market Forecast (USD Billion), by Germany, 2016-2027
      Figure 62: Europe Market Forecast (USD Billion), by France, 2016-2027
      Figure 63: Europe Market Forecast (USD Billion), by Italy, 2016-2027
      Figure 64: Europe Market Forecast (USD Billion), by Spain, 2016-2027
      Figure 65: Europe Market Forecast (USD Billion), by Russia, 2016-2027
      Figure 66: Europe Market Forecast (USD Billion), by Rest of Europe, 2016-2027
      Figure 67: Asia Pacific Biomarker Tests Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 68: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 69: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 70: Asia Pacific Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 71: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 72: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 73: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 74: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 75: Asia Pacific Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 76: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 77: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 78: Asia Pacific Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 79: Asia Pacific Market Forecast (USD Billion), by Others, 2016-2027
      Figure 80: Asia Pacific Market Forecast (USD Billion), by China, 2016-2027
      Figure 81: Asia Pacific Market Forecast (USD Billion), by India, 2016-2027
      Figure 82: Asia Pacific Market Forecast (USD Billion), by Japan, 2016-2027
      Figure 83: Asia Pacific Market Forecast (USD Billion), by Australia, 2016-2027
      Figure 84: Asia Pacific Market Forecast (USD Billion), by Southeast Asia, 2016-2027
      Figure 85: Asia Pacific Market Forecast (USD Billion), by Rest of Asia Pacific, 2016-2027
      Figure 86: Middle East & Africa Biomarker Tests Market Value Share (%), By Segment 1, 2019 & 2027
      Figure 87: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 88: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 89: Middle East & Africa Market Value Share (%), By Segment 2, 2019 & 2027
      Figure 90: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 91: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 92: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 93: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 94: Middle East & Africa Market Value Share (%), By Segment 3, 2019 & 2027
      Figure 95: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 1, 2016-2027
      Figure 96: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 2, 2016-2027
      Figure 97: Middle East & Africa Market Forecast (USD Billion), by Sub-Segment 3, 2016-2027
      Figure 98: Middle East & Africa Market Forecast (USD Billion), by Others, 2016-2027
      Figure 99: Middle East & Africa Market Forecast (USD Billion), by GCC, 2016-2027
      Figure 100: Middle East & Africa Market Forecast (USD Billion), by South Africa, 2016-2027
      Figure 101: Middle East & Africa Market Forecast (USD Billion), by Rest of Middle East & Africa, 2016-2027 
      List of Tables
      Table 1: Global Biomarker Tests Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 2: Global Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 3: Global Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 4: Global Market Revenue (USD Billion) Forecast, by Region, 2016-2027
      Table 5: North America Biomarker Tests Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 6: North America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 7: North America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 8: North America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 9: Europe Biomarker Tests Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 10: Europe Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 11: Europe Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 12: Europe Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 13: Latin America Biomarker Tests Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 14: Latin America Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 15: Latin America Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 16: Latin America Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 17: Asia Pacific Biomarker Tests Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 18: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 19: Asia Pacific Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 20: Asia Pacific Market Revenue (USD Billion) Forecast, by Country, 2016-2027
      Table 21: Middle East & Africa Biomarker Tests Market Revenue (USD Billion) Forecast, by Segment 1, 2016-2027
      Table 22: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 2, 2016-2027
      Table 23: Middle East & Africa Market Revenue (USD Billion) Forecast, by Segment 3, 2016-2027
      Table 24: Middle East & Africa Market Revenue (USD Billion) Forecast, by Country, 2016-2027

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934